Clinical Trials for Bolt Biotherapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Bolt Biotherapeutics

Clinical Trials (2)

NCT06921837
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
PHASE1/PHASE2Recruiting
122 participants
Started: May 26, 2025 · Completed: May 31, 2029
2 conditions1 sponsor3 locations
NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
PHASE1Active, not recruiting
147 participants
Started: Oct 11, 2023 · Completed: Mar 31, 2028
7 conditions2 sponsors6 locations